| ADA | Adalimumab |
| AI | Artificial Intelligence |
| aHR | Adjusted Hazard Ratio |
| aOR | Adjusted Odds Ratio |
| BWS | Bowel Wall Stratification |
| BWT | Bowel Wall Thickness |
| BUSS | Bowel Ultrasound Score |
| CDAI | Crohn’s Disease Activity Index |
| CD | Crohn’s Disease |
| CDS | Color Doppler Signal |
| CEUS | Contrast-Enhanced Ultrasound |
| CI | Confidence Interval |
| CTE | Computed Tomography Enterography |
| HR | Hazard Ratio |
| IBD | Inflammatory Bowel Disease |
| IBUS-SAS | International Bowel Ultrasound Segmental Activity Score |
| IFX | Infliximab |
| i-fat | Inflammatory Mesenteric Fat |
| IUS | Intestinal Ultrasound |
| JAK | Janus Kinase |
| MaRIA | Magnetic Resonance Index of Activity |
| MH | Mucosal Healing |
| MRE | Magnetic Resonance Enterography |
| MRI | Magnetic Resonance Imaging |
| OR | Odds Ratio |
| PICMI | Pediatric Inflammatory Crohn’s MRE Index |
| RISA | Risankizumab |
| sMaRIA | Simplified Magnetic Resonance Index of Activity |
| SUS-CD | Simple Ultrasound Score for Crohn’s Disease |
| SYSU | Sun Yat-sen University Score |
| TH | Transmural Healing |
| TNF | Tumor Necrosis Factor |
| UPA | Upadacitinib |
| UST | Ustekinumab |
| VDZ | Vedolizumab |